Registration of securities issued in business combination transactions

Unaudited Condensed Statement of Cash Flows

v3.21.4
Unaudited Condensed Statement of Cash Flows - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2020
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (526) $ (592,475)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Interest earned on cash and marketable securities held in Trust Account   (83,453)
Changes in operating assets and liabilities:    
Prepaid expenses   (354,086)
Accrued offering costs and expenses 500 401,055
Due to related party   30,214
Net cash used in operating activities (26) (598,746)
Cash flows from investing activities:    
Investment held in Trust Account   (276,000,000)
Net cash used in investing activities   (276,000,000)
Cash flows from financing activities:    
Proceeds from Initial Public Offering, net of underwriters' fees   270,480,000
Proceeds from private placement   7,270,000
Payments of offering costs   (651,036)
Proceeds from issuance of promissory note to related party 175,000  
Payment of promissory note to related party (25,000)  
Payment of deferred offering costs (114,360) (15,816,086)
Net cash provided by financing activities 35,640 277,098,964
Net change in cash 35,614 500,218
Cash, beginning of the period   35,614
Cash, end of the period 35,614 535,832
Supplemental disclosure of noncash investing and financing activities:    
Deferred underwriting commissions charged to additional paid-in capital   9,660,000
Initial value of common stock subject to possible redemption   276,000,000
Deferred offering costs paid by Sponsor loan   $ 18,773
Deferred offering costs included in accrued expenses 329,800  
Deferred offering costs paid by Sponsor in exchange for issuance of Common Stock $ 25,000